Many patients may keep off lost pounds after stopping a GLP-1

Among thousands of patients treated at a large network of U.S. academic medical clinics, most had kept the weight off or lost even more 18 months after stopping semaglutide, sold by Novo Nordisk as Ozempic and Wegovy, or tirzepatide, sold by Eli Lilly as Mounjaro and Zepbound, researchers from data analytics firm nference found.